Literature DB >> 17900698

Influence of ligand structure on Fe(II) spin-state and redox rate in cytotoxic tripodal chelators.

Matt L Childers1, Joonhyung Cho, Celeste A S Regino, Martin W Brechbiel, Antonio G DiPasquale, Arnold L Rheingold, Suzy V Torti, Frank M Torti, Roy P Planalp.   

Abstract

The Fe coordination chemistry of several tripodal aminopyridyl hexadentate chelators is reported along with cytotoxicity toward cultured Hela cells. The chelators are based on cis, cis-1,3,5-triaminocyclohexane (tach) with three pendant -CH2-2-pyridyl groups where 2-pyridyl is R-substituted thus are named tach-x-Rpyr where x=3, R=Me; x=3, R=MeO; x=6; R=Me. The structures of [Fe(tach-3-Mepyr)]Cl2 and [Fe(tach-3-MeOpyr)](FeCl4) are reported and their metric parameters indicate strongly bound, low-spin Fe(II). The structure of [Fe(tach-6-Mepyr)](ClO4)2 implies steric effects of 6-Me groups push donor Npy's away so one Fe-Npy bond is substantially longer at 2.380(3)A vs. 2.228(3)A for the others, and Fe(II) in the high-spin-state. Accordingly, anions X(-)=Cl or SCN afford [Fe(tach-6-Mepyr)(X)]+ from [Fe(tach-6-Mepyr)]2+ (UV-vis spectroscopy). Consistent with a biological cytotoxicity involving Fe chelation, chelators of low-spin Fe(II) have greater toxicity in the order [IC50(72 h) is in parentheses then the spin-state SS=H (high) or L (low)]: tachpyr=tach-3-Mepyr (6 microM, SS=L) greater, similar tach-3-MeOpyr (12microM, SS=L)>>tach-6-Mepyr (>200 microM, SS=H). Iron-mediated oxidative dehydrogenation with O2 oxidant removes hydrogens from coordinated nitrogen and the adjacent CH2, converting aqueous [Fe(tach-3-Rpyr)]2+ (R=H, Me and MeO) into a mix of low-spin imino- and aminopyridyl-armed complexes, but [Fe(tach-6-Mepyr)]2+ does not react (NMR and ESI-MS spectroscopies). The difference of IC(50) for chelators at different time points (delta IC50=[IC50(24h)-IC50(72 h)]) is used to compare rate of cytotoxic action to qualitative rate of oxidation in the Fe-bound chelator, giving the order, from rapid to slow oxidation and cell killing of: [Fe(tach-3-Mepyr)]2+ (delta IC50=5 microM)>[Fe(tachpyr)]2+ (delta IC50=16 microM)>[Fe(tach-3-MeOpyr)]2+ (delta IC50=118 microM). Thus, those chelators whose Fe(II) complexes undergo rapid oxidation kill cells faster, and those that bind Fe(II) as low-spin are far more cytotoxic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900698      PMCID: PMC2238680          DOI: 10.1016/j.jinorgbio.2007.07.039

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  12 in total

Review 1.  Novel chelating agents for potential clinical applications of copper.

Authors:  Dangshe Ma; Francis Lu; Terrish Overstreet; Diane E Milenic; Martin W Brechbiel
Journal:  Nucl Med Biol       Date:  2002-01       Impact factor: 2.408

2.  Novel cytotoxic chelators that bind iron(II) selectively over zinc(II) under aqueous aerobic conditions.

Authors:  R P Planalp; A M Przyborowska; G Park; N Ye; F H Lu; R D Rogers; G A Broker; S V Torti; M W Brechbiel
Journal:  Biochem Soc Trans       Date:  2002-08       Impact factor: 5.407

3.  Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator.

Authors:  Rong Zhao; Roy P Planalp; Rong Ma; Bryan T Greene; Bradley T Jones; Martin W Brechbiel; Frank M Torti; Suzy V Torti
Journal:  Biochem Pharmacol       Date:  2004-05-01       Impact factor: 5.858

4.  Preliminary evaluation of the cytotoxicity of a series of tris-2-aminoethylamine (Tren) based hexadentate heterocyclic donor agents.

Authors:  Suzy V Torti; Rong Ma; Vincent J Venditto; Frank M Torti; Roy P Planalp; Martin W Brechbiel
Journal:  Bioorg Med Chem       Date:  2005-11-01       Impact factor: 3.641

5.  Ligand Dehydrogenation in Ruthenium-Amine Complexes: Reactivity of 1,2-Ethanediamine and 1,1,1-Tris(aminomethyl)ethane.

Authors:  Paul Bernhard; Daryl J. Bull; Hans-Beat Bürgi; Peter Osvath; Andrea Raselli; Alan M. Sargeson
Journal:  Inorg Chem       Date:  1997-06-18       Impact factor: 5.165

6.  Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation.

Authors:  Jolyn Turner; Constantinos Koumenis; Timothy E Kute; Roy P Planalp; Martin W Brechbiel; Dillon Beardsley; Brooke Cody; Kevin D Brown; Frank M Torti; Suzy V Torti
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

7.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

Review 8.  Iron chelators in cancer chemotherapy.

Authors:  Joan L Buss; Bryan T Greene; Jolyn Turner; Frank M Torti; Suzy V Torti
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

9.  Tumor cell cytotoxicity of a novel metal chelator.

Authors:  S V Torti; F M Torti; S P Whitman; M W Brechbiel; G Park; R P Planalp
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

10.  Diastereospecific and diastereoselective syntheses of Ruthenium(II) complexes using N,N' bidentate ligands aryl-pyridin-2-ylmethyl-amine ArNH-CH2-2-C5H4N and their oxidation to imine ligands.

Authors:  Javier Gómez; Gabriel García-Herbosa; José V Cuevas; Ana Arnaiz; Arancha Carbayo; Asunción Muñoz; Larry Falvello; Phillip E Fanwick
Journal:  Inorg Chem       Date:  2006-03-20       Impact factor: 5.165

View more
  1 in total

Review 1.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.